HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kengo Akashi Selected Research

Sphenoid Sinusitis

1/2021Granulomatosis with Polyangiitis Presenting with Bilateral Orbital Apex Syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kengo Akashi Research Topics

Disease

9Rheumatoid Arthritis
07/2022 - 04/2015
3Systemic Scleroderma (Systemic Sclerosis)
01/2021 - 05/2015
2Dermatomyositis (Dermatopolymyositis)
11/2022 - 05/2015
2Connective Tissue Diseases (Connective Tissue Disease)
01/2022 - 05/2015
2Fibrosis (Cirrhosis)
01/2021 - 01/2016
2Arthritis (Polyarthritis)
11/2017 - 04/2015
1Myalgia
11/2022
1Muscular Dystrophies (Muscular Dystrophy)
11/2022
1Polymyositis
11/2022
1Rheumatic Diseases (Rheumatism)
07/2022
1Osteoporosis
07/2022
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
01/2022
1Uveitis
05/2021
1Hypertension (High Blood Pressure)
01/2021
1Sphenoid Sinusitis
01/2021
1Pulmonary Hypertension
01/2019
1Arthralgia (Joint Pain)
01/2019
1Rheumatoid Vasculitis
01/2019
1Neoplasms (Cancer)
11/2017
1Sclerosis
01/2016
1Atrophy
01/2016
1Hepatitis
01/2016
1Mixed Connective Tissue Disease (MCTD)
05/2015
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
05/2015
1Myositis (Idiopathic Inflammatory Myopathies)
05/2015
1Interstitial Lung Diseases (Interstitial Lung Disease)
05/2015
1Fever (Fevers)
05/2015

Drug/Important Bio-Agent (IBA)

4Antirheumatic Agents (DMARD)IBA
12/2020 - 01/2018
4Biological ProductsIBA
12/2020 - 01/2018
2Adalimumab (Humira)FDA Link
05/2021 - 01/2019
2CollagenIBA
01/2021 - 01/2016
2Pharmaceutical PreparationsIBA
01/2020 - 01/2018
2tofacitinibIBA
01/2020 - 04/2015
2Janus Kinase InhibitorsIBA
01/2020 - 04/2015
1plexinIBA
11/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
11/2022
1Biomarkers (Surrogate Marker)IBA
11/2022
1Monoclonal AntibodiesIBA
07/2022
1DenosumabFDA Link
07/2022
1Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric
01/2022
1Tumor Necrosis Factor InhibitorsIBA
01/2022
1GlucocorticoidsIBA
01/2022
1Atovaquone (Mepron)FDA Link
01/2022
1Immunoglobulin FragmentsIBA
01/2022
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
01/2022
1indium-bleomycinIBA
01/2021
1Soluble Guanylyl CyclaseIBA
01/2021
1GlutaminaseIBA
11/2017
1Glucose (Dextrose)FDA LinkGeneric
11/2017
1Glutamine (L-Glutamine)FDA Link
11/2017
1compound 968IBA
11/2017
1Endothelins (Endothelin)IBA
01/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2016
1Sulfasalazine (Azulfidine)FDA LinkGeneric
01/2016
1Endothelin-1 (Endothelin 1)IBA
01/2016
1DNA (Deoxyribonucleic Acid)IBA
01/2016
1Phosphates (Orthophosphate)IBA
01/2016
1Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2016
1AntibodiesIBA
05/2015
1Ligases (Synthetase)IBA
05/2015
1AutoantibodiesIBA
05/2015
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
05/2015
1ZymosanIBA
04/2015

Therapy/Procedure

1Therapeutics
05/2021
1Debridement
01/2021